Press monitoring
New Nanosensor Uses Quantum Dots to Detect DNA
6.4.2006 | Press monitoring
Using tiny semiconductor crystals, biological probes and a laser, Johns Hopkins University engineers have developed a new method of finding specific sequences of DNA by making them light up beneath a microscope. The researchers, who say the technique will have important uses in medical research, demonstrated its potential in their lab by detecting...
Prostate Cancer Biomarkers Found at Mayo
5.4.2006 | Press monitoring
Researchers at the Mayo Clinic, Rochester, Minn., identified changes in gene expression of the whole genome closely correlated to the development and progression of prostate cancer, and found that DNA hypermethylation is involved in the processes.
Bird flu vaccine promising in humans
5.4.2006 | Press monitoring
Tests in humans of an experimental vaccine against H5N1 avian influenza (bird flu) show that the vaccine is safe and spurs the immune response needed to protect against the deadly illness.
Stem cells from brains help rats walk, study says
5.4.2006 | Press monitoring
Stem cells harvested from the brains of mice can restore some walking ability in laboratory rats with spinal-cord damage
Principle and importance of using the array CGH in hematooncology
5.4.2006 | Press monitoring
Identification of chromosomal changes and variation in DNA copy number allows us to understand pathogenesis of tumors.
Avian flu: Influenza virus receptors in the human airway
5.4.2006 | Press monitoring
Although more than 100 people have been infected by H5N1 influenza A viruses, human-to-human transmission is rare1.
GM tomatoes may be key to bird flu fight
5.4.2006 | Press monitoring
Genetically-modified tomatoes may become a key weapon in the global fight against bird flu.
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy
5.4.2006 | Press monitoring
Researchers evaluated the use of a novel gene porter (Den123-a nontoxic self-assembled dendritic spheroidal nanoparticle made of biodegradable monomers), aiming to enhance and improve the desired immune response in protection from allergy.
Manufacturing contract for world-first cancer vaccine
5.4.2006 | Press monitoring
Anticipating a US Food and Drug Administration (FDA) approval this year, Dendreon has awarded Diosynth Biotechnology with a long-term contract to supply its novel vaccine for prostate cancer – the third most common cancer in the world.
